Julie Stevens
Family Medicine · Mount Pleasant, MINPI 1346246337
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $453 and has fallen 95.4% since, to $21 in 2025.
Across 98 payments — averaging $14.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$344
- Lilly USA, LLC$301
- Pfizer$145
- Amarin Pharma, Inc.$81
- Novartis$73
- Medtronic$68
- plus $452 from 16 others
What the payments were for
- Food & beverage$1,464100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 26 | $344 |
| Lilly USA, LLC | 22 | $301 |
| Pfizer | 9 | $145 |
| Amarin Pharma, Inc. | 5 | $81 |
| Novartis | 4 | $73 |
| Medtronic | 4 | $68 |
| Boehringer Ingelheim | 3 | $68 |
| Antares Pharma, Inc. | 5 | $67 |
| Astellas Pharma US Inc | 3 | $55 |
| Indivior Inc. | 2 | $31 |
| Neurocrine Biosciences, Inc. | 2 | $26 |
| AstraZeneca | 2 | $23 |
| GSK | 2 | $22 |
| Clarus Therapeutics Inc. | 1 | $22 |
| Amgen | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Abbott | 1 | $14 |
How this compares
$1,465 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 121 | $1,705 |
| Methadone Hcl | 25 | $534 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $418 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $312 |
| Carisoprodol | 13 | $161 |
| Atorvastatin Calcium | 12 | $157 |
| Gabapentin | 14 | $155 |
| Alprazolam | 13 | $24 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Mount Pleasant
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
- Timothy IzzoGrand Ledge$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.